Trastuzumab and syncope Patient Reports February 11, 2012

Trastuzumab Side Effects Report #5815558-5
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on June 30, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: syncope. Trastuzumab dosage: 4 MG/KG, SINGLE. During the same period patient was treated with DOCETAXEL. Patient recovered.

Trastuzumab Side Effects Report #5447595-7
Trastuzumab side effect was reported by a Physician from UNITED STATES on Aug 30, 2007. Female patient, 34 years of age, was diagnosed with breast cancer  and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: syncope. Trastuzumab dosage: 439 MG, SINGLE. During the same period patient was treated with NAVELBINE, OXYCONTIN. Patient recovered.

Trastuzumab Side Effects Report #5468217-5
Trastuzumab side effect was reported by a Physician from UNITED STATES on Sept 21, 2007. Female patient, 34 years of age, was diagnosed with breast cancer  and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: syncope. Trastuzumab dosage: 439 MG, SINGLE. During the same period patient was treated with NAVELBINE, OXYCONTIN. Patient recovered.

Trastuzumab Side Effects Report #5300510-9
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Apr 04, 2007. Female patient, weighting 196.2 lb, was diagnosed with breast cancer  and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: syncope. Trastuzumab dosage: 680 MG, UNK. During the same period patient was treated with CAPECITABINE, DOCETAXEL, EPIRUBICIN, CYCLOPHOSPHAMIDE, FRAXIPARIN, METOCLOPRAMIDE, DIMENHYDRINATE. Patient was hospitalized. Patient recovered.


Trastuzumab Side Effects Report #5307282-2
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Apr 13, 2007. Female patient, weighting 196.2 lb, was diagnosed with breast cancer  and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: ejection fraction decreased, syncope, tachycardia. Trastuzumab dosage: 680 MG, UNK. During the same period patient was treated with CAPECITABINE, DOCETAXEL, EPIRUBICIN, CYCLOPHOSPHAMIDE, FRAXIPARIN, METOCLOPRAMIDE, DIMENHYDRINATE. Patient was hospitalized. Patient recovered.